BLUE - Financial Reports List - bluebird bio, Inc. - IntrinsicAlpha

bluebird bio, Inc. BLUE

Healthcare - Biotechnology - NASDAQ - US

$ 4.34

-5.8 %

$ 42.5 M

Market Cap

-0.16

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	391.72%	67.56%	55.90%
Annual Report	FY	10-K	2024-12-31	184.12%	-13.59%	-10.73%
Quarterly Report	Q3	8-K	2024-09-30	-14.36%	15.23%	21.02%
Quarterly Report	Q2	8-K	2024-06-30	133.69%	-11.64%	-3.63%
Quarterly Report	Q1	8-K	2024-03-31	680.05%	-205.05%	-932.70%
Quarterly Report	Q4	8-K	2023-12-31	12535.48%	-274.62%	-325.04%
Annual Report	FY	10-K	2023-12-31	720.04%	20.51%	14.92%
Quarterly Report	Q3	8-K	2023-09-30	17353.52%	6.26%	2.02%
Quarterly Report	Q2	8-K	2023-06-30	353.59%	21.50%	20.58%
Quarterly Report	Q1	8-K	2023-03-31	22.42%	127.46%	107.01%

1